Hyoscine butylbromide - subcutaneous formulations Under review
Metadata
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- 2023 1.1.0
- Organisation
- OpenSAFELY
- Codelist ID
- opensafely/hyoscine-butylbromide-subcutaneous-formulations
- Version ID
- 4b7b43bc
- Number of codes included
- 4
About
Description
This codelist contains all subcutaneous formulations of hyoscine butylbromide.
Methodology
All AMPs and VMPs from the NHS dm+d have been mapped from relevant BNF codes. No exceptional cases were identified.
References
Signed off by
- Andrew Brown, (May 31, 2022)
- Richard Croker, (May 31, 2022)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| dmd_id | type | name | bnf_code |
|---|---|---|---|
| 3242611000001101 | AMP | Buscopan 20mg/1ml solution for injection ampoules | 0102000N0BBABAA |
| 36044111000001101 | VMP | Hyoscine butylbromide 20mg/1ml solution for injection ampoules | 0102000N0AAAAAA |
| 39145311000001101 | AMP | Hyoscine butylbromide 20mg/1ml solution for injection ampoules | 0102000N0AAAAAA |
| 40836611000001105 | AMP | Hyoscine butylbromide 20mg/1ml solution for injection ampoules | 0102000N0AAAAAA |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.